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Murine melanoma cells provide an excellent system for studying the proposed role of 
nuclear nonhistone proteins (NHP's) as regulators of gene expression. Cloudman mouse 
melanoma cells (891, NCTC 3960, CCL 53), grown in culture, are normally lightly 
pigmented, but in the presence of melanocyte stimulating hormone (MSH) show a large 
increase in melanin content. Cells were grown in medium with and without MSH and 
labeled with either '"C- or aH-leucine, respectively. Following 48 hr of incubation, the cells 
were harvested, combined, and nuclei isolated. The NHPs were extracted from these nuclei 
in a series of steps which yielded 4 major fractions. Each fraction was further separated on 
DEAE cellulose columns into a total of 40 subfractions, each of which was electrophoresed 
on SDS gels. Each gel was sliced and counted and the 14C/3H ratio was determined for each 
slice. A number of differences in 14C/3H ratios were observed between the NHPs isolated 
from MSH-treated and control cells which reflect changes in the synthesis and/or transport 
of NHPs in MSH-treated cells . 
Nuclear nonhistone proteins (NHPs) have been 
implicated in the control of genetic expression [1-
15]. We have used murine melanoma cells to test 
the proposed role of NHPs as regulatory proteins 
since the phenotype of the cell can be converted 
from amelanotic to melanotic by melanocyte sim-
ulating hormone (MSH). Moreover, tyrosinase is 
the only enzyme thus far identified with the oxi-
dation of tyrosine to melanin [16] . Accordingly, 
the cells from which the NHP's are being com-
pared may differ only in the synthesis or activa-
tion of this single enzyme. 
A Cloudman melanoma cell line was used 
which, although normally lightly pigmented, ex-
hibits a large increase in tyrosinase activity and 
melanin content in the presence of MSH [17- 19]. 
The effect of MSH on melanoma cells is mediated 
by adenosine 3',5' monophosphate (cAMP) [17-
22], perhaps at the transcriptional level by a block 
in the synthesis of an inhibitor of tyrosinase [18]. 
We have examined the NHPs in the melanoma 
cell following tyrosinase activation by MSH. 
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MATERIALS AND METHODS 
Culture Methods 
Mouse melanoma cells (Cloudman S91 NCTC 3960-
CCL 53) were grown in 250 ml Falcon culture flasks at 
37° in Ham's nutrient mix F-10 (GIBCO) supplemented 
with 2% fetal calf serum (GIBCO), 10% horse serum 
(GIBCO), 100 units/ml of penicillin, 100 f.Lg/ml of strep-
tomycin, and 1.2 mg/ml of sodium bicarbonate. Each 
flask was seeded with 1 x 10,; cells. After 48 hr the 
flasks were divided into 2 groups. To 1 group was 
added fresh F-10 medium lacking thymidine and leu-
cine and containing 0.66 mg/ml racemized MSH; 4 ,.,.Ci/ 
ml L-(U-' ''C) leucine (2.14 mCi/mg (New England Nu-
clear Boston, Mass); and 0.7 f.Lg/ml thymidine. To the 
other set was added F-10 medium without MSH includ-
ing 8.1 ,.,.Ci/ml L-(4, 5-3H) leucine (238 mCi/mg) (New 
England Nuclear), and 1.3 f.Lg/ml L-leucine. The final 
concentration of leucine in both groups was 2 f.Lg/ml 
(15 % of the concentration of!eucine in unaltered Ham's 
F-10 mixture). Cells were incubated in this medium for 
48 hours. 
Isolation of Nuclei 
Cells from each group of flasks were released from 
the substrate with Ca++ and Mg++ free Tyrode's solu-
tion containing 5 mM EDTA. The suspension was 
centrifuged for 5 minutes at 500 x g. The pellets were 
washed twice in 0.14 M NaCl and then homogenized in 
H buffer (0.05 M tricine , pH 7.5; 0.02 M KCl; 5 mM 
MgC12; 0.35 M sucrose) to which was added 3 mg/ml L-
leucine. The homogenates from the MSH and control 
groups were combined and centrifuged at 500 x g for 10 
min. The pellets were suspended in 2.2 M sucrose , 1.5 
mM CaCl2 and the suspension was centrifuged for 30 
min at 30,000 xg to sediment the nuclei [23]. 
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Extraction and Fractionation of Nuclear Nonhistone 
Proteins 
The extraction of NHPs from the purifi ed nuclei was 
a modification [23] of the method of Spelsberg et a! 
(27]. The nuclear pellets were homogenized if) NHP, 
buffer (10 mM Na P04 , pH 6; 2M NaCI; 5 M urea; 1 mM 
Mg Cl2; and 0.1% 13-mercaptoethanol) and then centri-
fuged for 24 hr at 105,000 g. The supernatant fraction 
contained the first nonhistone protein fraction (NHP,) 
plus histones. The pellet, which included the remaining 
nonhistone protein plus DNA was r esuspended in NHP2 
buffer (2 mM Tris-HCI, pH 7.5) and di a lyzed for 2 hr 
against the same solution. This suspension was then 
centrifuged at 800 g for 10 min to sediment the insoluble 
protein , NHP2 • The supernatant fraction, containing 
DNA with the remaining NHP's, was mixed with 2 vol 
of NHP, buffer (15 mM Tris, pH 8.5; 3.0 M NaCI; 7.5 M 
urea; 1.5 mM NaHSO,; 1.5 mM EDTA; and 0.1% 13-
mercaptoethanol) and a llowed to stand at -20°C for 2 
to 3 hr. This suspension was then centrifuged for 36 hr 
at 105,000 g. The supernatant fraction contained NHP, 
and the pellet contained DNA bound to the remaining 
protein fraction, NHP4 • Separation of NHP. from DNA 
was based [23] on a method of Teng, Teng, and Allfrey 
[6]. The pellet, containing DNA and NHP4 was sus-
pended in 5 vol of 0.1 M Tris-HCl, pH 8.4; 0.01 M 
EDTA, and 0.14 M ,B-mercaptoethanol (Buffer A). This 
suspension was mixed with an equa l volume of cold 
phenol saturated with Buffer A and allowed to stand 
for 18 hr at 4°C. The mixture was then briefly homoge-
nized and centrifuged at 12,000 g for 10 min. The 
phenol phase was collected and dialyzed at 4°C against 
0.1 M acetic acid containing 0.14 M ,B-mercaptoethanol 
with 1 cha nge until the phenol phase was reduced to 
about one-third of its original volume. The phenol 
phase was removed and dialyzed against 0.05 M acetic 
acid, 9.0 M urea, 0.14 M 13-mercaptoethanol for 22 to 24 
hr at 13°C. Dialysis was contained for 2 hr in NHP4 
buffer (0.1 M Tris-HCI , pH 8.4; 8.6 urea; 0.01 M EDTA; 
and 0.14 M ,B-mercaptoethanol). 
Each of the NHP fractions was subfractionated by 
column chromatography. NHP, was separated from 
the histones on Bio-Rex 70 (200-400 mesh , Na form, 
Bio-Rad Laboratories) [23]. The column was equili-
brated with the running buffer which contained 0.1 M 
NaP04 , pH 7.0; 6.0 M urea; 0.35 M guanidine hydrochlo-
ride (G-HCI); 0.1% 13-mercaptoethanol the NHP, plus 
histone fraction was dialyzed against the running 
buffer and applied to the column. The nonadsorbed 
peak contained NHP,. The histones were eluted from 
the column with 4 M G-HCI in the running buffer , 
followed by 7 M G-HCI. 
NHP,, NHP2 , and NHP, were each fractionated on 
DEAE-cellulose (DE-52, Whatman). The DEAE col-
umns were equilibrated with 0.01 M tris, pH 8.5; 3.0 M 
urea , 0.1 % 13-mercaptoethanol. NI-iP,, NHP2 , and NHP, 
were each dialyzed against the above buffer and applied 
to the column. The NHP's were eluted from the column 
with a series of 7 to 11 steps of increasing concentra-
tions of NaCI from 0.05 to 0.5 M. Residual protein was 
recovered in steps of 2M NaCl and 4 M and 7 M G-HCI. 
The columns were monitored by counting aliquots of 
each fraction in 10 ml Scintisol (lsolab , Inc. , Akron, 
Ohio) on a Nuclear Chicago Mark II scintillation 
counter . The fractions were pooled and frozen at -70°C. 
Gel Electrophoresis 
The 40 NHP fractions were dia lyzed against distilled 
water, lyophylized, and further fractionated on 10% 
polyacrylamide SDS gels, 90 x 6 mm [23] . The gels 
were frozen , sli ced t ransversly in to 1-mm sections, 
and placed in scint ill ation vials containing 8 ml of the 
following mixture: 20 ml 4 N NH,OH; [100 ml NCS 
solubilizer (Amersham/Searle Co.); and 1000 ml Liqui-
fluor-toluene (1:24) (New England Nuclear Corp.). 3H 
and 14C were measured simultaneously in a Nuclear 
Chicago Mark II Scintillation Counter. Counting effi-
ciency was 41 '1! for ''H and 55% for 14C. The data were 
corrected for background and spillover and the "C/"H 
ratios calculated. The significant differences in ratio , 
indicated by a rrows in the figure , were observed in 
duplicate or triplicate gels and in a duplicate experi-
ment. 
RESULTS 
An eightfold increase in tyrosinase activity [24] 
was observed in the present set of experiments 
after the cells were exposed to MSH for 48 hr . 
During this period the cell number increased in 
the control group from 8 x 107 to 13 x 107 and in 
the MSH-treated group from 8 x 107 to 12.6 x 107. 
The 4 NHP fractions (NHP,-NHP.,) as well as 
histones plus basic proteins contained between 80 
and 95% of the total nuclear protein in the follow-
ing proportions: NHP,, 30-40%; NHP2 , 10-20%; 
NHPa, 3-5%; NHP4 , 0.3-0.4%; and histones plus 
basic proteins, 30-35%. When the proteins were 
electrophoresed on polyacrylamide gels several 
differences were found between the 14C/'1H ratios 
of the NHPs from melanotic and amelanotic cells.* 
In NHP, the 0.05 M NaCl fraction exhibited 2 
regions where the "C!"H ratio decreased corre-
sponding to proteins of roughly 17,000 and 26,000 
daltons (Fig 1c). A decrease in the '·'C/"H ratio 
was also observed in the 65,000 molecular weight 
region of the proteins in the 0.075 M fraction (Fig 
1d). Slight increases in the 14/C3H ratios were 
observed in 14,000 a nd 22,000 molecular weight 
proteins in the 0.10 fraction (Fig 1e). The 14C/3H 
ratios of the 0.15 M NaCl fraction (Fig 1{! and 0.35 
M-2 M NaCI and 4 M-7M guanidine-HCI fractions 
were relatively invariant as exemplified by the 
0.4 M NaCI fraction (Fig 1g). 
In NHP2 variation in the ratios was probably 
related to the low number of counts in the sample 
applied to the gel. A slight increase in '·'CI"H 
ratio was observed in the class of 70,000 dalton 
proteins in the 4 M guanidine-HCl fraction (Fig 2c). 
* The statistica l significance of observed changes in 
"CI"H ratios was evaluated in two ways. In the first 
method , the point which most extremely deviated from 
the mean was selected , and a value was calculated 
based on the sample size (60-80 slices), which would be 
significant in a one-tailed test of significance. At the 
1% level , this value was 3.6 SD and at the 5% level, 
3.2 SD. This calculation was taken from the adjusted 
significance test proposed by Cooper [25]. The second 
method for evaluating significance was based on an a 
posteriori probability model. The significance of an 
observed deviation from the mean was determmed by 
estimating the probability of such a deviation occurring 
at the same point as well as in the same direction in 
duplicate gels to 0.02 % for triplicate sampl es. In a ll 
figures , those variations in the ratios which were 
significant according to one or both tests are noted by 
arrows. 
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FIG 1. Changes in the labeling of NHP 1 fractions 
from MSH-treated melanoma cells . NHP, fractions 
were eluted from a DEAE-cellulose column with in-
creasing salt concentrations as described in Materials 
a nd Methods . The pooled peaks were prepared and 
electrophoresed on SDS gels following the protocol of 
Teng et al [6]. Gels were sli ced transversely into 1-mm 
sections and each slice was counted for 20 min . The 
data were corrected for background and '''C spillover 
and the 14C/"H ratio was calculated for each slice. The 
mean and SD for each ratio are shown. Those variations 
in the ratios which are significant are noted by arrows. 
(a) molecular weight range of protein standards (see 
Materials and Methods). ( b) unretained material (c) 
0.05 M NaCl fraction (d) 0.075 M NaCI fraction (e) 0.10 
M NaCl fraction ({J 0.15 M NaCl fraction (g) 0.4 M 
NaCI fraction. - - - = •·•c cpm (MSH-treated cells) and 
-- = "H cpm (control cells). 
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FIG 2. Changes in the labeling of NHP2 fractions 
from MSH-treated melanoma cell s. The fractions were 
eluted from a DEAE-cellulose column and electropho-
resed on SDS gels. The protocol is the same as described 
in Fig 1. (a) molecular weight standards; ( b ) 0.5 M 
NaCI fraction; (c) 4.0 M G-HCI fraction; - -- = 14C 
cpm (MSH-treated cells); -- = '1H cpm. 
In NHP" were found the major differences. In 
the 0.10 M, 0.125 M and 0.15 M fractions (Fig 3b-
3d), there were several variations in the ratios. In 
particular, there was a large increase in the 14C-
labeled proteins of 20,000-22,000 daltons and 
smaller increases for 1'1C-labeled proteins of 11,000 
and 15,000 daltons. In the 0.125 M and 0.15 M 
fractions, increases in •·•C-labeled proteins of mo-
lecular weight 70,000 were also observed . 
Since NHP4 contained less protein than the 
other fractions, it was applied to SDS gels without 
prior subfractionation on DEAE. A large decrease 
in the 14C-labeled proteins ranging from 10,000-
16,000 daltons was observed (Fig 4b). 
DISCUSSION 
The alterations in the 1'1C/'1H ratios reflect in-
creases or decreases in synthesis and/or transport 
of particular NHP's between the cytoplasm and 
nucleus in the MSH-treated cells [26]. The most 
striking differences appear in NHPa where there 
are increases in NHP's of 20,000 and 70,000 daltons 
from MSH-treated cells. Spelsberg et al [27] have 
also found that in chick oviduct, the AP,1 fraction 
(which corresponds to NHPa) contains proteins 
responsible for binding the progesterone-receptor 
complex to the chromatin. In other systems as 
well , the synthesis of NHP's is selectively stimu-
lated by hormones such as hydrocortisone [28] 
and estradiol [29] in hepatic and uterine tissue, 
respectively, and by phytohemagglutinin in 
lymphoid cells [30]. The variations in '''CPH ratios 
reflect changes in NHP's which could be involved 
in the regulation of any of the steps leading to the 
synthesis of melanin. The alterations in NHP's 
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FIG 3. Changes in the labeling of NHPa fractions 
from MSH-treated melanoma cells. The fractions were 
eluted from a DEAE-cellulose column and electropho-
resed on SDS gels . The protocol is the same as described 
in Fig 1. (a) molecular weight standards; (b) 0.100 M 
NaCl fraction; (c) 0.125 M NaCI fraction; (d) 0.150 M 
NaCI fraction; (e) 0.20 M NaCI fraction; ({J 4.0 M G-
HCI fraction; - - - = ••c cpm (MSH-treated cells); --
= 
3H cpm (control cells). 
could also reflect metabolic or morphological 
changes caused by increased intracellular cAMP 
[18 ,22]. The observed changes in NHP's in MSH-
treated cells could be either a cause or a conse-
quence of the response of the cells to the hormone [2 ,31]. 
By extensive subfractionation we have greatly 
increased the a bility to detect small differences in 
specific NHP's. Total nuclear protein rather than 
chromatin was extracted to avoid losing soluble 
nonbound NHP's. Even with these improved 
methods for isola ting and fractionating NHP's it 
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FIG 4. SDS gel of NHP., from melanoma cells treated 
with and without MSH. The sample was prepared and 
electrophoresed as in Fig 1. (a) molecular weight stan-
dards; (b) NHP4 fraction;- - -= •·•c cpm (MSH-treated 
cells);-- = "H cpm (control cells). 
is possible that changes in the amounts and types 
of proposed regulatory chromosomal proteins may 
escape detection. If a structural gene is repre-
sented by a nonreiterated sequence of DNA and 
has a single associated regulatory protein our 
method may not be sufficiently sensitive to detect 
a change associated with such a gene. Nonethe-
less, the analysis of melanoma cells which have 
such distinctive responses to hormones optimizes 
the identification of the hypothetical r egulatory 
proteins wi thin the population ofNHP's. Recently , 
each of the 4 NHP fractions has been found to 
bind homologous DNA and influence template 
activity (Wikswo and McGuire, in preparation). 
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